Iftekhar Mahmood

4.6k total citations
168 papers, 3.3k citations indexed

About

Iftekhar Mahmood is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Computational Theory and Mathematics. According to data from OpenAlex, Iftekhar Mahmood has authored 168 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pharmacology, 47 papers in Pediatrics, Perinatology and Child Health and 31 papers in Computational Theory and Mathematics. Recurrent topics in Iftekhar Mahmood's work include Pharmacogenetics and Drug Metabolism (56 papers), Pharmaceutical studies and practices (41 papers) and Computational Drug Discovery Methods (31 papers). Iftekhar Mahmood is often cited by papers focused on Pharmacogenetics and Drug Metabolism (56 papers), Pharmaceutical studies and practices (41 papers) and Computational Drug Discovery Methods (31 papers). Iftekhar Mahmood collaborates with scholars based in United States, Bangladesh and Pakistan. Iftekhar Mahmood's co-authors include John Dikran Balian, Chandra Sahajwalla, Million A. Tegenge, Marilyn N. Martinez, Robert P. Hunter, Kosalaram Goteti, Ke Liu, Marc R. Theoret, Xiaobin Lü and Shiowjen Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Clinical Cancer Research.

In The Last Decade

Iftekhar Mahmood

155 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iftekhar Mahmood United States 31 1.0k 741 712 675 569 168 3.3k
Hannah M. Jones United States 36 1.4k 1.4× 1.1k 1.5× 1.3k 1.8× 524 0.8× 319 0.6× 105 3.8k
Neil Parrott Switzerland 37 1.5k 1.5× 1.0k 1.4× 1.3k 1.8× 713 1.1× 573 1.0× 125 4.5k
Johan Gabrielsson Sweden 29 523 0.5× 964 1.3× 344 0.5× 263 0.4× 397 0.7× 106 3.3k
Jeffrey S. Barrett United States 39 646 0.6× 717 1.0× 445 0.6× 1.3k 2.0× 929 1.6× 192 5.0k
Kyung‐Sang Yu South Korea 32 704 0.7× 918 1.2× 799 1.1× 597 0.9× 612 1.1× 333 4.5k
Piet H. van der Graaf Netherlands 32 518 0.5× 1.7k 2.3× 455 0.6× 212 0.3× 333 0.6× 149 3.8k
Harold Boxenbaum United States 28 1.0k 1.0× 748 1.0× 707 1.0× 338 0.5× 644 1.1× 73 3.7k
Andrew C. Hooker Sweden 21 333 0.3× 559 0.8× 543 0.8× 531 0.8× 741 1.3× 109 3.8k
Wayne A. Colburn United States 34 577 0.6× 1.1k 1.5× 585 0.8× 513 0.8× 462 0.8× 136 3.9k
Donald E. Mager United States 39 553 0.5× 2.1k 2.8× 1.1k 1.5× 262 0.4× 521 0.9× 167 5.5k

Countries citing papers authored by Iftekhar Mahmood

Since Specialization
Citations

This map shows the geographic impact of Iftekhar Mahmood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iftekhar Mahmood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iftekhar Mahmood more than expected).

Fields of papers citing papers by Iftekhar Mahmood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iftekhar Mahmood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iftekhar Mahmood. The network helps show where Iftekhar Mahmood may publish in the future.

Co-authorship network of co-authors of Iftekhar Mahmood

This figure shows the co-authorship network connecting the top 25 collaborators of Iftekhar Mahmood. A scholar is included among the top collaborators of Iftekhar Mahmood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iftekhar Mahmood. Iftekhar Mahmood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmood, Iftekhar, et al.. (2024). Explore how Gender Influences the Expression of Aggression in Anxious Individuals Considering Socialization and Cultural Expectation. Review of Applied Management and Social Sciences. 7(4). 267–285.
3.
Mahmood, Iftekhar. (2023). Application of Allometric Scaling and Salisbury Rule for the Prediction of Antimalarial Drugs for First-in-Pediatric Dose Selection. European Journal of Drug Metabolism and Pharmacokinetics. 48(5). 587–594.
4.
Mahmood, Iftekhar, et al.. (2023). IMPACT OF SHORTAGE OF STAFF NURSES ON QUALITY CARE OF PATIENTS AT SPECIALISED HOSPITALS IN LAHORE. Biological and Clinical Sciences Research Journal. 2023(1). 409–409. 1 indexed citations
6.
O’Leary, Maura, Xiaobin Lü, Ying Huang, et al.. (2018). FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia. Clinical Cancer Research. 25(4). 1142–1146. 221 indexed citations
7.
Mahmood, Iftekhar, et al.. (2013). A population pharmacokinetic model of remifentanil in pediatric patients using body-weight-dependent allometric exponents. Drug metabolism and drug interactions. 28(4). 231–237. 12 indexed citations
8.
Mahmood, Iftekhar. (2012). Interspecies scaling of biliary excreted drugs: prediction of human clearance and volume of distribution. Drug metabolism and drug interactions. 27(3). 157–164. 7 indexed citations
9.
Mahmood, Iftekhar. (2012). Prediction of drug concentration-time profiles of therapeutic proteins in humans from animals. Xenobiotica. 43(2). 153–160. 3 indexed citations
10.
Mahmood, Iftekhar. (2012). Allometric extrapolation of factors VII, VIII and IX clearance in children from adults. Journal of Thrombosis and Haemostasis. 10(8). 1609–1613. 5 indexed citations
11.
Mahmood, Iftekhar. (2011). Pharmacokinetic Allometric Scaling of Oligonucleotides. Nucleic Acid Therapeutics. 21(5). 315–321. 10 indexed citations
12.
Mahmood, Iftekhar. (2010). Prediction of drug clearance in children 3 months and younger: an allometric approach. Drug metabolism and drug interactions. 25(1-4). 25–34. 16 indexed citations
13.
Goteti, Kosalaram, C. Edwin Garner, & Iftekhar Mahmood. (2009). Prediction of Human Drug Clearance from Two Species: A Comparison of Several Allometric Methods. Journal of Pharmaceutical Sciences. 99(3). 1601–1613. 12 indexed citations
14.
Mahmood, Iftekhar. (2009). Pharmacokinetic allometric scaling of coagulation factors and tissue‐type plasminogen activators. Haemophilia. 15(5). 1109–1117. 8 indexed citations
15.
Shoaib, Nosherwan, Mujeeb Ahmad, & Iftekhar Mahmood. (2008). Design, fabrication & testing of Low Noise Amplifier at Ku-Band. 18–23. 1 indexed citations
16.
Mahmood, Iftekhar, et al.. (2008). Speech Recognition using Dynamic Time Warping. 74–79. 49 indexed citations
17.
Mahmood, Iftekhar & Chandra Sahajwalla. (2002). Interspecies scaling of biliary excreted drugs. Journal of Pharmaceutical Sciences. 91(8). 1908–1914. 48 indexed citations
18.
Mahmood, Iftekhar. (1999). Allometric issues in drug development†. Journal of Pharmaceutical Sciences. 88(11). 1101–1106. 58 indexed citations
19.
Mahmood, Iftekhar & John Dikran Balian. (1996). Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica. 26(9). 887–895. 196 indexed citations
20.
Mahmood, Iftekhar, Steven H. Neau, & William D. Mason. (1994). An enzymatic assay for the MAO-B inhibitor selegiline in plasma. Journal of Pharmaceutical and Biomedical Analysis. 12(7). 895–899. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026